---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-089218"
form_type: "8-K"
ticker: "AMRN"
cik: "0000897448"
company_name: "AMARIN CORP PLCUK"
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T23:10:55.431082+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Amarin licenses VAZKEPA to Recordati in Europe; launches restructuring targeting $70M annual savings

## Summary
- Upfront $25M and up to $150M in milestone payments; Recordati to commercialize VAZKEPA in 59 European countries.
- Global restructuring to cut operating costs by ~$70M annually; expects $30-37M in restructuring charges in Q2 2025.
- Company retains U.S. rights; nearly $300M cash on hand, no debt; accelerated path to positive cash flow.
- Agreement term 15 years, auto-renewal subject to commercialization in at least one country.

## SEC filing metadata
- accession: 0000950170-25-089218
- form_type: 8-K
- ticker: AMRN
- cik: 0000897448
- company_name: AMARIN CORP PLCUK
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/897448/000095017025089218/0000950170-25-089218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/897448/000095017025089218/amrn-20250620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-089218
- JSON: https://secwatch.observer/filing/0000950170-25-089218.json
- Plain text: https://secwatch.observer/filing/0000950170-25-089218.txt

## Key facts
- Restructurings & Charges
  AMARIN CORP PLCUK announced a restructuring with charges of between approximately $30 million and $37 million affecting Europe operations.
  - Type: restructuring
  - Charge: between approximately $30 million and $37 million
  - Affected area: Europe operations
  source text: On June 24, 2025, as described in the Press Release, the Company announced a global restructuring, with the vast majority of estimated cost savings from reduced commercialization expense from the Company’s Europe operations. The Company expects these actions will reduce operating costs by approximately $70 million annually and is anticipated to be substantially completed by June 30, 2026. Amarin anticipates that it will incur between approximately $30 million and $37 million in charges related to the restructuring, substantially all of which are cash expenditures for one-time termination benefits and associated costs.
  evidence_url: https://www.sec.gov/Archives/edgar/data/897448/000095017025089218/0000950170-25-089218-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.